Attached files

file filename
8-K - 8-K - UFP TECHNOLOGIES INCufpt-20160802x8k.htm

Exhibit 99.1

 

UFP Technologies, Inc.

www.ufpt.com

100 Hale Street

Contact: Ron Lataille

Newburyport, MA 01950 USA

978-234-0926, rlataille@ufpt.com

 

FOR IMMEDIATE RELEASE

 

UFP Technologies Announces Q2 Results

 

Newburyport, Mass., August 2, 2016.  UFP Technologies, Inc.  (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, composites, and natural fiber materials, today reported net income of $2.7 million or $0.38 per diluted common share outstanding for its second quarter ended June 30, 2016, a 20.4% increase over net income of $2.3 million or $0.32 per diluted common share outstanding for the same period in 2015. Sales for the second quarter were $37.9 million, 3.8% higher than second quarter sales of $36.5 million in 2015.  Net income for the six-month period ended June 30, 2016 was $3.8 million or $0.53 per diluted common share outstanding compared to $3.9 million or $0.55 for the same period in 2015.  Sales for the six-month period ended June 30, 2016 were $72.4 million, compared to sales of $70.5 million for the same period in 2015.

 

“I am pleased with our second quarter results and progress,” said R. Jeffrey Bailly, Chairman and CEO.  “We have seen steady improvements in both our top and bottom lines, as the inefficiencies and extra labor associated with our plant moves and re-qualifications have begun to give way to the synergies we anticipated. Revenue grew nearly 4% over last year’s Q2, and has improved steadily throughout the year. A 31% decrease in military sales compared to the second quarter of 2015 was more than offset by 12% sales growth in our largest market, medical/biotech.”

 

“We also made good progress attracting new talent for key positions, including a general manager for our largest facility, our 250,000-square-foot Michigan operation,” Bailly continued.  “And we have had increased activity on the acquisition front. With our ERP implementation completed and final plant consolidation mostly behind us, we feel we now have the bandwidth to integrate a new acquisition.”

 

“With continued growth anticipated in our medical business, our Northeast consolidation moving toward completion, increased acquisition activity, and an infusion of energetic new talent, we are bullish about our future,” said Bailly.

 

UFP Technologies is an innovative designer and custom converter of foams, plastics, composites, and natural fiber materials, principally serving the medical, automotive, aerospace and defense, electronics, consumer, and industrial markets. The UFP team acts as an extension of our customers’ in-house research, engineering, and manufacturing groups, working closely with them to solve their most complex product and packaging challenges.

 

 

This news release contains statements relating to expected financial performance and/or future business prospects, events and plans that are forward-looking statements.  Such statements include, but are not limited to, statements about the Company’s prospects, statements about the Company’s acquisition strategies and opportunities, statements regarding new hires and anticipated trends in the different markets in which the Company competes, anticipated advantages relating to the Company’s decisions to consolidate its facilities and the expected cost savings and efficiencies associated therewith, anticipated advantages of maintaining fewer, larger plants, anticipated advantages the Company expects to realize from its investments and capital expenditures, expectations regarding the manufacturing capacity and efficiencies of the Company, statements about the Company’s participation and growth in multiple markets, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues, and any indication that the Company may be able to sustain or increase its sales and earnings or sales and earnings growth rates.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation risks and uncertainties associated with the identification of suitable acquisition candidates and the successful, efficient execution of acquisition transactions and integration of any such acquisition candidates, risks and uncertainties associated with plant closures and expected efficiencies from consolidating manufacturing, risks that the Company may not be able to finalize anticipated new customer contracts, risks associated with the implementation of new production equipment and requalification or recertification of transferred equipment, in a timely, cost-efficient manner, risks that any benefits from such new or transferred equipment may be delayed or not fully realized, or that the Company may be unable to fully utilize its expected production capacity, as well as other risks and uncertainties that are detailed in the documents filed by the Company with the Securities and Exchange Commission (“SEC”).  Accordingly, actual results may differ materially.  Readers are referred to the documents filed by the Company with the SEC, specifically the last reports on Forms 10-K and 10-Q.  The forward-looking statements contained herein speak only of the Company’s expectations as of the date of this press release.  The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in the Company’s expectations or any change in events, conditions, or circumstances on which any such statement is based.

 


 

 

 

UFP Technologies, Inc.

Q2 2016 earnings

 

Consolidated Condensed Statements of Income

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

    

2016  

    

2015  

    

2016  

    

2015  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

37,902 

 

$

36,499 

 

$

72,406 

 

$

70,476 

 

Cost of sales

 

 

27,616 

 

 

26,206 

 

 

54,393 

 

 

51,544 

 

Gross profit

 

 

10,286 

 

 

10,293 

 

 

18,013 

 

 

18,932 

 

SG&A

 

 

6,470 

 

 

6,776 

 

 

12,374 

 

 

12,800 

 

Restructuring costs

 

 

55 

 

 

30 

 

 

178 

 

 

108 

 

Material overcharge settlement

 

 

(432)

 

 

-

 

 

(432)

 

 

-

 

Gain on sale of fixed assets

 

 

-

 

 

-

 

 

(4)

 

 

(31)

 

Operating income

 

 

4,193 

 

 

3,487 

 

 

5,897 

 

 

6,055 

 

Interest income (expense), net

 

 

15 

 

 

 

 

26 

 

 

(15)

 

Income before income taxes

 

 

4,208 

 

 

3,495 

 

 

5,923 

 

 

6,040 

 

Income taxes

 

 

1,473 

 

 

1,223 

 

 

2,113 

 

 

2,114 

 

Net income from consolidated operations

 

$

2,735 

 

$

2,272 

 

$

3,810 

 

$

3,926 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share outstanding

 

$

0.38 

 

$

0.32 

 

$

0.53 

 

$

0.55 

 

Net income per diluted share outstanding

 

$

0.38 

 

$

0.32 

 

$

0.53 

 

$

0.55 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

7,196 

 

 

7,116 

 

 

7,185 

 

 

7,096 

 

Weighted average diluted shares outstanding

 

 

7,271 

 

 

7,210 

 

 

7,263 

 

 

7,203 

 

 

Consolidated Condensed Balance Sheets

(in thousands)

 

 

 

 

 

 

 

 

 

 

    

June 30,

    

December 31,

 

 

 

2016 

 

2015 

 

 

 

 

(unaudited)

 

 

 

 

Assets:

 

 

 

 

 

 

 

Cash

 

$

27,007 

 

$

29,804 

 

Receivables

 

 

23,020 

 

 

17,481 

 

Inventories

 

 

13,884 

 

 

14,202 

 

Other current assets

 

 

3,075 

 

 

2,116 

 

Net property, plant, and equipment

 

 

48,325 

 

 

46,555 

 

Other assets

 

 

9,668 

 

 

9,792 

 

Total assets

 

$

124,979 

 

$

119,950 

 

Liabilities and equity:

 

 

 

 

 

 

 

Short-term debt

 

$

1,020 

 

$

1,011 

 

Accounts payable

 

 

5,463 

 

 

4,598 

 

Other current liabilities

 

 

4,769 

 

 

5,374 

 

Long-term debt

 

 

345 

 

 

859 

 

Other liabilities

 

 

4,872 

 

 

4,536 

 

Total liabilities

 

 

16,469 

 

 

16,378 

 

Total equity

 

 

108,510 

 

 

103,572 

 

Total liabilities and stockholders' equity

 

$

124,979 

 

$

119,950